Rapamycin analogs with reduced systemic exposure

Bioorganic & Medicinal Chemistry Letters
2005.0

Abstract

The synthesis and biological activities of rapamycin (I) analogs modified at the C-40 position are reported. Emphasis placed on compounds that potentially have an improved safety profile on account of their shorter in vivo half-life when compared with rapamycin.

Knowledge Graph

Similar Paper